This was the stock's fourth consecutive day of gains.

Shares of Abbott Laboratories (NYSE:ABT) and DexCom (NASDAQ:DXCM) traded higher on Tuesday after Secretary of the U.S.

A whistleblower’s False Claims Act suit filed in 2021 alleging fraudulent diabetic supplies billing by Arriva Medical LLC, ...

Illinois-based Abbott Laboratories required job applicants to disclose their family medical histories in violation of the state’s Genetic Information Privacy Act, a proposed federal class action said.